U.S. Wireless Telecom Stock News

NetApp stock has delivered a strong 136.2% return over the past 5 years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the shares trading below their assessed value. That combination of a strong track record and indications of undervaluation puts the focus squarely on whether the current price around US$167.74 is still reasonable for new capital. Over 5 years, NetApp has returned 136.2%, which puts long term holders in a comfortable...

A recent UBS report spotlighted DLocal (NasdaqGS:DLO) as a key opportunity in global payment processing, highlighting its broad emerging markets footprint and prompting fresh attention on how the stock fits into diversified portfolios. See our latest analysis for DLocal. The recent UBS attention comes as DLocal’s share price, now at US$14.49, has logged a 30 day share price return of 18.0% and a 1 year total shareholder return of 36.1%. Longer term total shareholder returns have been more...

Dime Commercial Bancshares has almost doubled shareholders' money over the past three years, yet its current valuation checks and recent share price of US$39.56 point to a stock that screens as undervalued rather than obviously overheated. The stock has returned 95.8% over the last three years, which puts recent short term pullbacks in a wider context of strong longer term gains. For a regional lender like Dime Commercial Bancshares, investor expectations around loan growth and credit...

Lamar Advertising stock has delivered a strong 91.8% total return over the past five years, and the current valuation tension is that both the intrinsic value estimate from a Discounted Cash Flow (DCF) approach and market multiples now suggest the shares trade at a discount to their estimated worth. Over five years, Lamar Advertising has returned 91.8%, which puts more focus on whether the current price still offers an attractive entry point based on fundamentals. The company’s ability to...

Repligen has entered into a definitive agreement to acquire BioLife Solutions, the cell therapy tools company traded as NasdaqCM:BLFS. Following the deal announcement, several law firms have launched investigations into whether the transaction is fair to BioLife Solutions shareholders. The probes focus on the sale process, potential conflicts, and whether investors are receiving adequate value for their shares. BioLife Solutions sits at the intersection of cell and gene therapy workflows,...

Honeywell International (HON) has put up a striking Q2 2026 print, with revenue of about US$9.7 billion and basic EPS of US$17.92, while trailing 12 month figures show revenue of roughly US$38.1 billion and EPS of US$26.04 backed by net income of US$8.3 billion. Over the past few quarters, the company has seen revenue move between roughly US$8.9 billion and US$10.4 billion as EPS ranged from US$0.98 to US$5.75 before the latest spike. This leaves investors to weigh how much of the current...

Mondelez International stock has gained 12.8% year to date, yet its valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to significant upside while market multiples suggest the shares already trade on the rich side. The 12.8% year to date return suggests the market has recently been more optimistic about Mondelez International, even though longer term returns have been less supportive. Investment in emerging snack brands such as Final Boss...

Utah Medical Products (UTMD) opened Q2 2026 with total revenue of $8.5 million and basic EPS of $0.84, alongside net income excluding extra items of $2.7 million, providing a clear snapshot of how the business is currently earning its money. The company has reported quarterly revenue moving from $9.7 million and EPS of $0.92 in Q1 2025 to $8.5 million and EPS of $0.84 in Q2 2026, with trailing 12 month revenue at $36.1 million and EPS at $3.28. Investors are weighing these results against a...

City Holding (CHCO) shares are in focus after the company reported second quarter and six month 2026 results, with higher net interest income and largely unchanged net income compared with last year. See our latest analysis for City Holding. City Holding’s latest earnings and buyback update come as the stock trades at $139.62, with a 30-day share price return of 6.33% and a year-to-date share price return of 16.46%, while the 5-year total shareholder return of 112.58% indicates momentum has...

Cass Information Systems (CASS) has just posted Q2 2026 revenue of US$54.5 million and basic EPS of US$0.83, with the trailing twelve months showing US$215.0 million of revenue and basic EPS of US$2.83 as the latest snapshot of its earnings power. Over recent quarters the company has seen revenue move from US$48.6 million in Q2 2025 to US$54.0 million in Q3 2025, US$53.4 million in Q4 2025, US$53.1 million in Q1 2026 and now US$54.5 million. Quarterly basic EPS shifted from US$0.39 in Q2 2025...

AtriCure (ATRC) has put fresh numbers on the table for Q2 2026, reporting revenue of US$153.6 million and basic EPS of US$0.18, alongside net income of US$9.0 million. These results come as the trailing twelve months show EPS of US$0.22 on revenue of US$569.6 million and net income of US$10.6 million. Over the past six quarters, the company has seen quarterly revenue move from US$123.6 million in Q1 2025 to US$153.6 million in Q2 2026, while basic EPS has shifted from a loss of US$0.14 to a...

Goosehead Insurance (NasdaqGS:GSHD) announced that CEO Mark Miller plans to retire, with the transition scheduled for January 2027. President and COO Mark Jones Jr., who has also served as CFO, is set to succeed Miller as Chief Executive Officer at that time. The planned handover outlines a multiyear succession path that keeps leadership within the existing executive team. Goosehead Insurance, a personal lines insurance agency platform, sits in a sector where distribution models, customer...

On July 16, 2026, Insmed announced positive 12‑month data from its ongoing open-label extension study of once-daily treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension, showing sustained improvements in six-minute walk distance, NT-proBNP, WHO Functional Class, and REVEAL Lite 2.0 score, with no new safety signals identified. A particularly striking finding was that about 65% of patients achieved Refined Low Risk status, a category associated with a very low...

Ameriprise Financial (AMP) opened Q2 2026 with total revenue of US$5.0 billion and basic EPS of US$12.12, while trailing 12 month revenue sat at US$19.8 billion with EPS of US$41.99 and earnings growth over the past year of 22.4%. Over recent quarters the company has seen revenue move from US$4.9 billion in Q1 2026 to US$5.0 billion in Q2 2026. Over the same period, quarterly EPS shifted from US$9.81 to US$12.12, as trailing net income reached US$4.0 billion. With net profit margins at 19.9%...

Kearny Financial (KRNY) just wrapped up FY 2026 with Q4 revenue of US$44.9 million and EPS of US$0.11, while trailing twelve month revenue came in at US$176.4 million and EPS at US$0.58, alongside earnings growth of 39.1% over the past year. Over recent periods the company has seen revenue move from US$151.6 million and EPS of US$0.42 on a trailing basis in FY 2025 to the current US$176.4 million and US$0.58 respectively, with net profit margin up from 17.2% to 20.6% over the same horizon...

UBS has highlighted progress in Starbucks' US turnaround efforts. The analyst update points to recovery in core operations and customer engagement across the US business. UBS also flagged potential for US comparable sales to outperform current market expectations. Starbucks, NasdaqGS:SBUX, is back in focus as attention shifts from short term share price moves to what is happening inside its largest market. The stock last closed at $103.25, with the company up 23.0% year to date and 12.2%...

LiveWire Group (LVWR) has posted Q2 2026 revenue of US$9.1 million, with EPS at a loss of US$0.09 and net income excluding extra items at a loss of US$18.2 million, keeping the story firmly focused on how quickly the business can scale to cover its cost base. The company has seen quarterly revenue move between US$2.7 million and US$11.4 million over the last six reported periods, while EPS losses have stayed in a tight band around US$0.09 per share. The trailing twelve months reflect revenue...

Recent analysis of Palomar Holdings (PLMR) centers on growth in net premiums earned and book value per share, with consensus expectations for further BVPS gains over the next year drawing investor attention. See our latest analysis for Palomar Holdings. At a share price of $137.56, Palomar Holdings has seen firm short term momentum, with a 15.68% 30 day share price return and a 9.11% 90 day share price return, while the 3 year total shareholder return of 128.58% points to a stock that has...

Recent commentary on Signet Jewelers highlights that the company currently holds a favorable Zacks Rank of #2 (Buy) and a Value grade of A, with valuation measures such as PEG, price-to-book, and price-to-sales suggesting the stock may be undervalued relative to specialty retail peers. Analysts had been anticipating that Signet’s upcoming earnings release would show higher earnings per share and steady revenue versus last year, and this combination of perceived undervaluation and expected...

Interest in Xcel Energy (XEL) has picked up after its role at the Yotta 2026 conference on AI and energy, along with a new Google data center power agreement in Minnesota and a US$60.00 billion clean energy capital program. See our latest analysis for Xcel Energy. At a share price of US$81.67, Xcel Energy has seen momentum build recently, with a 7 day share price return of 3.68% and a year to date share price return of 9.36%, while the 1 year total shareholder return of 15.86% and 3 year...

Fresh out of its Q2 2026 report, NovoCure (NVCR) posted total revenue of US$183.6 million and a basic EPS loss of US$0.13, with trailing twelve month revenue at US$699.2 million and a full year EPS loss of US$1.31. The company has seen quarterly revenue move from US$158.8 million in Q2 2025 to US$183.6 million in Q2 2026. Basic EPS losses across recent quarters have ranged from US$0.31 to US$0.62, underlining an earnings profile that remains in the red even as top line figures scale higher...

Dorchester Minerals (DMLP) declared a second quarter 2026 cash distribution of $1.272943 per common unit, tied to activity through June 30 and payable on August 13 to unitholders of record on August 3. See our latest analysis for Dorchester Minerals. At a share price of $27.79, Dorchester Minerals has seen near term momentum build with a 1 month share price return of 8.47% and a year to date share price return of 19.53%. Its 5 year total shareholder return of 181.60% points to a materially...

Pelagos Insurance Capital (PLGO) drew fresh attention after analysts raised their consensus earnings outlook by 7% over the past two months, along with an upgrade to Zacks Rank #1 and recognition as a top value stock. See our latest analysis for Pelagos Insurance Capital. Pelagos Insurance Capital has also seen solid share price momentum, with a 30 day share price return of 7.03% and a 22.04% gain over 90 days. The 1 year total shareholder return of 69.16% and 3 year total shareholder return...

Terreno Realty (TRNO) is back in focus after a series of industrial lease announcements, including early renewals and expansions in New York and California that extend occupancy commitments well into the next decade. See our latest analysis for Terreno Realty. Recent lease wins in New York and California come as Terreno Realty’s share price sits at $72.68, with a 30-day share price return of 11.06% and a 1-year total shareholder return of 31.83%. This suggests momentum has been building over...